<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-050671</identifier>
<setSpec>1130-0108</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Helicobacter pylori: its discovery and relevance for medicine</dc:title>
<dc:description xml:lang="en">In 1979, Warren was first to observe these bacteria in an inflamedgastric epithelium, and subsequently in peptic ulcer-associatedgastritis. In 1981, Marshall starts his research and cultivatesthe bacteria, performs prospective studies, and administers therapyregimens using antibiotics and bismuth salts. The organism wasdesignated Campylobacter-like after its similarity with said genus.In 1984, Marshall manages to meet Koch's postulates using selfinoculationby ingesting a bacterial culture, which resulted in gastritisthat was then treated and cured with bismuth salts andmetronidazole. The Gastroenterological Society of Australia rejectedthe abstract with preliminary data. In 1983, &#147;The Lancet&#148;published such data in two brief letters with the same heading,with each being signed by one of these two researchers. Cooperatingwith microbiologists they classify the new bacteria within theHelicobacter genus as the pylori species. Gastritis and peptic ulcerare currently considered infectious diseases. Their diagnosisand therapy include bacterial detection methods and antibiotics,respectively. In addition, a causal relationship between Helicobacterpylori and both gastric adenocarcinoma and gastric lymphomahas been established, and its association with some extradigestiveconditions has been suggested</dc:description>
<dc:creator>Pajares, J. M</dc:creator>
<dc:creator>Gisbert, J. P</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">En 1979, por primera vez, Warren observó la bacteria en elepitelio gástrico inflamado y, posteriormente, en gastritis asociadasa úlcera péptica. En 1981, Marshall inicia la colaboración obteniendoel cultivo, realizando estudios prospectivos y administrandopautas terapéuticas con antibióticos y sales de bismuto.Llaman Campylobacter-like a la bacteria, por su parecido conesta especie. En 1984, Marshall logra cumplir los postulados deKoch con la autoinoculación por ingestión de un cultivo de la bacteriaque origina gastritis, tratada y curada con sales de bismuto ymetronidazol. La Asociación Australiana de Gastroenterología rechazael abstract con los datos preliminares. En 1983, Lancet lospublica en dos breves cartas, con el mismo título, firmadas separadamentepor los dos investigadores. En colaboración con microbiólogosclasifican la nueva bacteria, dentro del género Helicobacter,como pylori. Actualmente, la gastritis y la úlcera péptica sonconsideradas enfermedades infecciosas. En su diagnóstico y tratamientose incluyen, respectivamente, métodos de detección de labacteria y antibióticos. Además, se ha comprobado la relacióncausal entre Helicobacter pylori y el adenocarcinoma y el linfomagástrico, y se ha sugerido su relación con algunas enfermedadesextradigestiva</dc:description>
<dc:source>Rev Esp Enferm Dig;98(10): 770-785, oct. 2006. ilus</dc:source>
<dc:identifier>ibc-050671</dc:identifier>
<dc:title xml:lang="es">Helicobacter pylori: su descubrimiento e importancia en la medicina</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d29157^s22034</dc:subject>
<dc:subject>^d29156^s22001</dc:subject>
<dc:subject>^d5900^s22046</dc:subject>
<dc:subject>^d10633^s22046</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d4442^s22046</dc:subject>
<dc:subject>^d29157</dc:subject>
<dc:type>article</dc:type>
<dc:date>200610</dc:date>
</metadata>
</record>
</ibecs-document>
